オプションチェーンは、Telix Pharmaceuticalsの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、Telix Pharmaceuticalsの市場センチメントを評価します。.

Telix Pharmaceuticals (NASDAQ:TLX) 株価情報, オプションチェーン

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Telix Pharmaceuticals

Telix Pharmaceuticals Limited - American Depositary Shares

Telix Pharmaceuticals Ltd

On Monday, the FDA accepted the supplemental biologics license application (sBLA) for Bristol Myers Squibb&nbsp;&amp; Co&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>) Opdivo&nbsp;(nivolumab) plus&nbsp;Yervoy&nbsp;(ipilimumab) as a potential first-line treatment option for adult and pediatric patients (12 years and older) with unresectable or metastatic microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/b43908522/u-s-food-and-drug-administration-accepts-bristol-myers-squibbs-supplemental-biologics-license-appl" rel="noreferrer noopener">colorectal cancer (mCRC)</a>.
The FDA granted the application Breakthrough Therapy Designation and Priority Review status. It also assigned a Prescription Drug User Fee Act (PDUFA) goal date of June 23, 2025.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/02/43597173/whats-going-on-with-bristol-myers-squibb-stock-on-monday" rel="noreferrer noopener">What&#8217;s Going On With Bristol Myers Squibb Stock On Monday?</a>
The application was based on results from the three-arm Phase 3 CheckMate -8HW study, which demonstrated that Opdivo plus Yervoy&nbsp;met the dual primary endpoints of progression-free survival (PFS) compared to the investigator&#8217;s choice of chemotherapy in the first-line setting and compared to&nbsp;Opdivo&nbsp;monotherapy across all lines of therapy.
Opdivo&nbsp;plus&nbsp;Yervoy&nbsp;received FDA approval in July 2018 for adult and pediatric patients 12 years and older with MSI-H or dMMR mCRC that have progressed following treatment with fluoropyrimidine, oxaliplatin and irinotecan.&nbsp;
Opdivo&nbsp;plus&nbsp;Yervoy&nbsp;was also approved in December 2024 in the&nbsp;European Union&nbsp;for the first-line treatment of adult patients with MSI-H or dMMR unresectable or mCRC and in October 2024 for the same indication by the China National Medical Products Administration.
Last week, Bristol Myers announced the final analysis of overall survival (OS) from the Phase 3 CheckMate -816 study. The trial evaluated Opdivo (nivolumab) in combination with platinum-doublet chemotherapy as a neoadjuvant treatment for adult patients with resectable non-small <a href="https://www.benzinga.com/25/02/43830315/bristol-myers-lead-cancer-drug-opdivo-in-combination-with-chemo-shows-improved-overall-survival-in-certain-patients-with-lung-cancer" target="_blank" rel="noreferrer noopener">cell lung cancer (NSCLC)</a>.
The results showed a statistically significant and clinically meaningful improvement in overall survival, a key secondary endpoint, compared to neoadjuvant chemotherapy alone.
Price Action: Bristol Myers stock is up 2.97% at $57.49 at last check Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/contracts/25/02/43911011/raytheon-elcan-secures-key-contract-to-supply-dual-role-sights-to-danish-armed-forces" target="_blank" rel="noreferrer noopener">Raytheon ELCAN Secures Key Contract To Supply Dual-Role Sights To Danish Armed Forces</a></li>
</ul>
Image: Courtesy of Bristol Myers Squibb

Biotech

Large Cap

News

Health Care

Movers

Trading Ideas

General

Bristol Myers Colorectal Cancer Treatment Goes Under Priority FDA Review

Cloud software company Salesforce, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) significantly expanded its strategic partnership with Google to offer businesses greater flexibility in selecting AI models and capabilities for building<a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/b43911729/salesforce-and-google-bring-gemini-to-agentforce-enable-more-customer-choice-in-major-partnership-" rel="noreferrer noopener"> and deploying AI-driven agents</a>.
The enhanced partnership strengthens customers&#8217; ability to leverage data, AI, and trust to integrate autonomous agents into their businesses effectively.
Through this expanded partnership, Salesforce customers can now build Agentforce agents using Gemini and deploy Salesforce on Google Cloud.
This builds upon their existing collaboration, which enables seamless, bidirectional data integration between Data Cloud and Google BigQuery using zero-copy technology.
This partnership extends beyond core product integrations, creating a more connected and intelligent data foundation for businesses.
Salesforce and Google Cloud said they are committed to continuous innovation, with deeper collaboration planned throughout 2025.
Enhanced integrations across Data Cloud, BigQuery, and Cortex Framework will streamline secure AI agent deployment using enterprise data.
Additionally, new native integrations between Tableau, Looker, and BigQuery will enable businesses to manage and visualize data seamlessly within a unified interface, ensuring standardized business logic and data definitions.
Earlier this month, Salesforce declared its intention&nbsp;to invest in&nbsp;Saudi Arabia to bolster <a target="_blank" href="https://www.benzinga.com/markets/25/02/43616463/salesforce-and-aws-pledge-500m-to-boost-ai-development-in-saudi-arabia" rel="noreferrer noopener">artificial intelligence (AI) development</a>.
Investors can gain exposure to the stock via&nbsp;iShares Expanded Tech-Software Sector ETF&nbsp;(BATS:<a class="ticker" href="https://www.benzinga.com/stock/IGV#BATS">IGV</a>) and REX FANG &amp; Innovation Equity Premium Income ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FEPI#NASDAQ">FEPI</a>).
Price Action: CRM shares are up 0.14% at $310.22 at the last check Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43681134/palantir-ceo-alex-karp-western-software-superiority-will-make-america-stronger-as-stock-soars-368-on-ai-boom" target="_blank" rel="noreferrer noopener">Palantir CEO Alex Karp Says Western Software Superiority Will Make America &#8216;Stronger&#8217; As Burgeoning AI Demand Pushes Stock Up 368%</a></li>
</ul>
Photo via Shutterstock.

Equities

Tech

FEPI

Salesforce & Google Supercharge AI: New Partnership Unlocks Next-Gen Business Automation

Shares of Block Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYZ#NYSE">XYZ</a>) continued to tank in early trading on Monday, after having <a href="https://www.benzinga.com/quote/xyz">lost around 20% last week</a>.
The sell-off in the company's stock following the release of fourth-quarter results has created an "attractive entry point," according to BMO Capital Markets.
The Block Analyst: <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/6203b5d2e008470001d757b2/rufus-hone">Analyst Rufus Hone</a> upgraded the rating for Block from Market Perform to Outperform, while raising the price target from $100 to $89.
The Block Thesis: While market sentiment is now "more balanced," there is less downside risk to Street estimates, Hone said in the upgrade note.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
Square appears well-positioned to benefit from "product innovations, incremental distribution enhancements, and the refreshed sales strategy," which could drive gross profit and gross payment volume higher, the analyst stated.
"Square&#8217;s 4Q24 GPV growth was a bright spot, coming in slightly better than expected (driven by better U.S. trends), while near-term GP growth expectations have moderated," he wrote.
Growth in Cash App's average revenue per user (ARPU) could remain robust, "driven by strong contributions from Cash App Borrow, BNPL, Cash App Pay and Afterpay on Cash App Card, underpinning a pronounced GP acceleration," Hone further said. The acceleration in gross profits could be back-end weighted, he added.
Price Action: Shares of Block had declined by 4.67% to $65.16 at the time of publication on Monday.
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/25/01/42922091/spacex-apple-airbnb-and-more-companies-pitch-in-to-support-california-residents-after-wildfires-we-want-to-help">Block Shares Fairly Valued, Analysts Say Stock &#8216;Not For The Faint Of Heart&#8217;</a></li>
</ul>
Image: Shutterstock

Block's Square, Cash App Poised For 2H-Weighted Profit Growth: Analyst

Macro Economic Events

Politics

Economics

US SEC Plans To Cut Regional Directors Under Cost Scrutiny From Trump Administration, Sources Say

Financial giants have made a conspicuous bullish move on Enphase Energy. Our analysis of options history for Enphase Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>) revealed 8 unusual trades.
Delving into the details, we found 75% of traders were bullish, while 25% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $213,180, and 4 were calls, valued at $399,090.
<h3>Projected Price Targets</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $56.0 to $85.0 for Enphase Energy over the last 3 months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Enphase Energy's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Enphase Energy's significant trades, within a strike price range of $56.0 to $85.0, over the past month.
<h3>Enphase Energy Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740417340_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ENPH</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$7.25</td>
<td>$6.9</td>
<td>$7.2</td>
<td>$60.00</td>
<td>$144.0K</td>
<td>2.1K</td>
<td align="right">2</td>
</tr>
<tr>
<td>ENPH</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$15.0</td>
<td>$14.85</td>
<td>$14.85</td>
<td>$70.00</td>
<td>$142.5K</td>
<td>694</td>
<td align="right">51</td>
</tr>
<tr>
<td>ENPH</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/07/25</td>
<td>$0.34</td>
<td>$0.29</td>
<td>$0.3</td>
<td>$56.00</td>
<td>$95.0K</td>
<td>186</td>
<td align="right">11</td>
</tr>
<tr>
<td>ENPH</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$14.7</td>
<td>$13.55</td>
<td>$14.7</td>
<td>$70.00</td>
<td>$72.0K</td>
<td>694</td>
<td align="right">1</td>
</tr>
<tr>
<td>ENPH</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$7.1</td>
<td>$6.9</td>
<td>$6.9</td>
<td>$70.00</td>
<td>$57.2K</td>
<td>5.5K</td>
<td align="right">20</td>
</tr>
</tbody>
</table>

<h3>About Enphase Energy</h3>
Enphase Energy is a global energy technology company. The company delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Geographically, it derives a majority of revenue from the United States.
After a thorough review of the options trading surrounding Enphase Energy, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Where Is Enphase Energy Standing Right Now?</h3>
<ul>
<li>With a volume of 1,229,191, the price of ENPH is up 1.63% at $65.91. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 57 days.</li>
</ul>
<h3>What Analysts Are Saying About Enphase Energy</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $80.4.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Guggenheim upgraded its action to Neutral with a price target of $62. 
&#x2A; Maintaining their stance, an analyst from Wells Fargo continues to hold a Overweight rating for Enphase Energy, targeting a price of $77. 
&#x2A; Maintaining their stance, an analyst from Barclays continues to hold a Overweight rating for Enphase Energy, targeting a price of $86. 
&#x2A; Consistent in their evaluation, an analyst from Craig-Hallum keeps a Buy rating on Enphase Energy with a target price of $101. 
&#x2A; An analyst from Susquehanna persists with their Neutral rating on Enphase Energy, maintaining a target price of $76. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Enphase Energy with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

Options

Markets

ENPH

Looking At Enphase Energy's Recent Unusual Options Activity

Deep-pocketed investors have adopted a bearish approach towards UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in UNH usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 75 extraordinary options activities for UnitedHealth Group. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 33% leaning bullish and 57% bearish. Among these notable options, 37 are puts, totaling $2,292,046, and 38 are calls, amounting to $16,785,124.
<h3>Projected Price Targets</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $350.0 to $900.0 for UnitedHealth Group over the recent three months. 
<h3>Volume &amp; Open Interest Trends</h3>
In today's trading context, the average open interest for options of UnitedHealth Group stands at 458.23, with a total volume reaching 16,888.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in UnitedHealth Group, situated within the strike price corridor from $350.0 to $900.0, throughout the last 30 days.
<h3>UnitedHealth Group 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740417335_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>UNH</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$151.0</td>
<td>$145.15</td>
<td>$151.0</td>
<td>$350.00</td>
<td>$14.3M</td>
<td>5.5K</td>
<td>1.0K</td>
</tr>
<tr>
<td>UNH</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$150.8</td>
<td>$145.0</td>
<td>$149.7</td>
<td>$350.00</td>
<td>$673.6K</td>
<td>5.5K</td>
<td>51</td>
</tr>
<tr>
<td>UNH</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$44.5</td>
<td>$43.9</td>
<td>$44.5</td>
<td>$460.00</td>
<td>$400.5K</td>
<td>492</td>
<td>4</td>
</tr>
<tr>
<td>UNH</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>12/19/25</td>
<td>$35.85</td>
<td>$35.0</td>
<td>$35.85</td>
<td>$500.00</td>
<td>$253.7K</td>
<td>188</td>
<td>63</td>
</tr>
<tr>
<td>UNH</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$34.7</td>
<td>$33.75</td>
<td>$33.8</td>
<td>$460.00</td>
<td>$185.8K</td>
<td>368</td>
<td>8</td>
</tr>
</tbody>
</table>

<h3>About UnitedHealth Group</h3>
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to about 51 million members globally, including 1 million outside the us as of December 2024. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Following our analysis of the options activities associated with UnitedHealth Group, we pivot to a closer look at the company's own performance.
<h3>Where Is UnitedHealth Group Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 3,233,606, the UNH's price is down by -0.98%, now at $461.84. </li>
<li>RSI readings suggest the stock is currently may be oversold.</li>
<li>Anticipated earnings release is in 50 days.</li>
</ul>
<h3>Professional Analyst Ratings for UnitedHealth Group</h3>
A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $660.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Wells Fargo has decided to maintain their Overweight rating on UnitedHealth Group, which currently sits at a price target of $660. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for UnitedHealth Group, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

This Is What Whales Are Betting On UnitedHealth Group

Whales with a lot of money to spend have taken a noticeably bullish stance on Lululemon Athletica.
Looking at options history for Lululemon Athletica (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) we detected 21 trades.
If we consider the specifics of each trade, it is accurate to state that 57% of the investors opened trades with bullish expectations and 14% with bearish.
From the overall spotted trades, 10 are puts, for a total amount of $2,736,755 and 11, calls, for a total amount of $539,059.
<h3>Expected Price Movements</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $290.0 to $430.0 for Lululemon Athletica over the last 3 months. 
<h3>Volume &amp; Open Interest Trends</h3>
In terms of liquidity and interest, the mean open interest for Lululemon Athletica options trades today is 404.15 with a total volume of 2,388.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Lululemon Athletica's big money trades within a strike price range of $290.0 to $430.0 over the last 30 days.
<h3>Lululemon Athletica Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740417330_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>LULU</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$20.65</td>
<td>$17.95</td>
<td>$19.46</td>
<td>$290.00</td>
<td>$1.9M</td>
<td align="right">801</td>
<td align="right">0</td>
</tr>
<tr>
<td>LULU</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$11.85</td>
<td>$11.45</td>
<td>$11.51</td>
<td>$310.00</td>
<td>$475.3K</td>
<td align="right">536</td>
<td align="right">414</td>
</tr>
<tr>
<td>LULU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>04/17/25</td>
<td>$16.75</td>
<td>$16.1</td>
<td>$16.34</td>
<td>$390.00</td>
<td>$110.3K</td>
<td align="right">96</td>
<td align="right">83</td>
</tr>
<tr>
<td>LULU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$16.45</td>
<td>$15.95</td>
<td>$16.18</td>
<td>$390.00</td>
<td>$82.5K</td>
<td align="right">96</td>
<td align="right">196</td>
</tr>
<tr>
<td>LULU</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>02/28/25</td>
<td>$15.05</td>
<td>$13.7</td>
<td>$14.25</td>
<td>$375.00</td>
<td>$71.2K</td>
<td align="right">168</td>
<td align="right">54</td>
</tr>
</tbody>
</table>

<h3>About Lululemon Athletica</h3>
Lululemon Athletica designs, distributes, and markets athletic apparel, footwear, and accessories for women, men, and girls. Lululemon offers pants, shorts, tops, and jackets for both leisure and athletic activities such as yoga and running. The company also sells fitness accessories, such as bags, yoga mats, and equipment. Lululemon sells its products through more than 700 company-owned stores in about 20 countries, e-commerce, outlets, and wholesale accounts. The company was founded in 1998 and is based in Vancouver, Canada.
<h3>Present Market Standing of Lululemon Athletica</h3>
<ul>
<li>With a trading volume of 703,542, the price of LULU is up by 1.57%, reaching $364.62.</li>
<li>Current RSI values indicate that the stock is may be oversold.</li>
<li>Next earnings report is scheduled for 24 days from now.</li>
</ul>
<h3>Expert Opinions on Lululemon Athletica</h3>
2 market experts have recently issued ratings for this stock, with a consensus target price of $497.5.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Oppenheimer has decided to maintain their Outperform rating on Lululemon Athletica, which currently sits at a price target of $500. 
&#x2A; An analyst from Evercore ISI Group has decided to maintain their Outperform rating on Lululemon Athletica, which currently sits at a price target of $495. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Lululemon Athletica options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

LULU

Looking At Lululemon Athletica's Recent Unusual Options Activity

Shares of oil and gas major, Chevron Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>) are <a href="https://www.benzinga.com/movers">trading higher</a> on Monday.
The company revealed major changes to its leadership structure as part of efforts to <a href="https://www.benzinga.com/pressreleases/25/02/b43911755/chevron-announces-senior-leadership-changes">optimize its organizational setup </a>and enhance long-term competitiveness. 
Chevron is consolidating its Oil, Products &amp; Gas division into two segments: Upstream and Downstream, Midstream &amp; Chemicals.
The company stated that this move is designed to streamline operations, speed up decision-making, and set the company up for future growth and success.
Chevron has appointed Mark Nelson to remain at the helm of the Oil, Products &amp; Gas division as vice chairman and executive vice president. 
Also Read: <a href="https://www.benzinga.com/25/02/43911212/tiktok-collaboration-powers-connexas-new-mena-strategy-stocks-skyrocket">TikTok Collaboration Powers Connexa&#8217;s New MENA Strategy</a>
He will manage the company's updated strategy for splitting the Upstream and Downstream, Midstream &amp; Chemicals sectors, a move aimed at improving standardization across regions and boosting efficiency. 
Clay Neff, who currently serves as the president of International Exploration and Production, will take on the role of president of Upstream starting July 1, 2025. Meanwhile, Bruce Niemeyer, president of Americas Exploration and Production, will be assigned to lead Shale &amp; Tight operations starting on the same date.
In addition, the Downstream, Midstream &amp; Chemicals organization will undergo significant changes. Andy Walz will continue to serve as president, overseeing vital work processes related to operations, commercial activities, and customer value chain optimization.
&#8220;Our new organizational structure and leadership appointments are designed to improve our operational efficiency and position Chevron for sustained growth,&#8221; said CEO and Chairman Mike Wirth.
It is to be noted that Chevron recently said it is <a href="https://www.benzinga.com/markets/25/02/43685595/chevron-announces-about-20-workforce-reduction-in-cost-saving-initiative-responsible-leadership-requires-taking-these-steps">planning to begin layoffs this year</a>, with most expected to be completed by the end of 2026. 
This initiative is part of a larger cost-reduction strategy, with the company aiming to save between $2 billion and $3 billion by 2026.
In its fourth-quarter earnings, the company posted an adjusted EPS of $2.06, <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/01/43399866/chevrons-free-cash-flow-outlook-tops-estimates-goldman-sachs-sees-upside">missing the consensus of $2.11</a>.
Price Action: CVX shares are trading higher by 0.78% at $158.14 at last check Monday.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43913537/why-is-penny-stock-foresight-autonomous-gaining-today">Why Is Penny Stock Foresight Autonomous Gaining Today?</a></li>
</ul>
Photo: Shutterstock

What's Going On With Chevron Stock Today?

Diamondback Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FANG#NASDAQ">FANG</a>) and Viper Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VNOM#NASDAQ">VNOM</a>) are heading into <a href="https://www.benzinga.com/earnings">fourth-quarter earnings</a> under heavy bearish pressure, but their technical setups reveal contrasting signals for investors.
<h1 class="wp-block-heading">FANG Stock Stuck In Reverse</h1>
Diamondback Energy stock has slumped 12.09% over the past year and is down 6.65% year-to-date. The stock sits below its five-, 20- and 50-day exponential moving averages (EMAs), signaling a strongly bearish trend.
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent022425&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="629" height="489" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/24112249/Screenshot-2025-02-24-at-9.51.27-PM.png" alt="" class="wp-image-795854" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/24112249/Screenshot-2025-02-24-at-9.51.27-PM.png 629w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/24112249/Screenshot-2025-02-24-at-9.51.27-PM-300x233.png 300w" sizes="(max-width: 629px) 100vw, 629px" /></a></figure>
<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent022425&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">Chart created using Benzinga Pro</a>
Diamondback Energy stock's eight-day simple moving average (SMA) of $157.44, 20-day SMA of $162.17 and 50-day SMA of $165.17 all flash bearish signals, as the stock trades beneath each level. Even the 200-day SMA of $183.45 reinforces this downside outlook.
The Moving Average Convergence Divergence (MACD) indicator sits at a negative 3.42, further supporting the bearish case. Meanwhile, the Relative Strength Index (RSI) at 37.44 suggests the stock is nearing oversold territory but not yet primed for a rebound.
Read Also: <a href="https://www.benzinga.com/trading-ideas/movers/25/02/43675485/eqt-viper-energy-shares-decline-amid-gas-price-volatility-and-capital-discipline-focus">EQT, Viper Energy Shares Decline Amid Gas Price Volatility And Capital Discipline Focus</a>
<h1 class="wp-block-heading">VNOM Stock: Bearish Short Term, Bullish Underneath</h1>
Viper Energy stock tells a slightly different story. While the stock is down 4.41% year to date, it&#8217;s still up 33.45% over the past year, reflecting stronger relative performance. 
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent022425&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="629" height="489" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/24112302/Screenshot-2025-02-24-at-9.51.44-PM.png" alt="" class="wp-image-795855" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/24112302/Screenshot-2025-02-24-at-9.51.44-PM.png 629w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/24112302/Screenshot-2025-02-24-at-9.51.44-PM-300x233.png 300w" sizes="(max-width: 629px) 100vw, 629px" /></a></figure>
<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent022425&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">Chart created using Benzinga Pro</a>
Viper Energy stock at $47.74 sits below its eight-day SMA of $49.57, 20-day SMA of $48.85 and 50-day SMA of $49.36 — all bearish signals similar to the stock&#8217;s signals.
However, Viper Energy's 200-day SMA of $46.11 offers a bullish signal, as the current price trades above this long-term support. The MACD indicator at a negative 0.05 further supports the short-term bearish signals, while the RSI at 41.11 and declining suggests the stock is approaching oversold conditions without being extreme.
<h1 class="wp-block-heading">Investor Takeaway</h1>
Both Diamondback Energy and Viper Energy face short-term bearish pressure, but Viper Energy's strength above its 200-day SMA and positive MACD hint at a potential rebound. Diamondback Energy, on the other hand, lacks similar support and remains firmly in bearish territory. 
As earnings approach, investors may find Viper Energy the comparatively stronger play — unless Diamondback Energy delivers an earnings surprise that flips the script.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/02/43916277/streaming-stocks-revenues-quadrupled-but-shares-dropped-35-analyst-thinks-he-knows-why">Streaming Stock&#8217;s Revenues Quadrupled, But Shares Dropped 35% &#8211; Analyst Thinks He Knows Why</a></li>
</ul>
Photo: Shutterstock

Technicals

Commodities

Previews

FANG

VNOM

Diamondback Energy Vs. Viper Energy: Which Stock Has The Edge Ahead Of Q4 Earnings?

Baker Hughes Company&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKR#NASDAQ">BKR</a>) shares are trading lower on Monday. The company disclosed the appointment of Ahmed Moghal as its new <a target="_blank" href="https://www.benzinga.com//node/43911780" rel="noreferrer noopener">chief financial officer, effective immediately.</a>
He will succeed Nancy Buese, who, by mutual agreement with the company, ceased to serve as CFO effective today. She will transition to a strategic adviser role and will leave the company on April 30, 2025.
Moghal, who is currently serving as CFO of the company&#8217;s Industrial &amp; Energy Technology (IET) business, previously held senior roles across various business and corporate functions.
Lorenzo Simonelli, Baker Hughes chairman and chief executive officer, said, &#8220;The news we are announcing today reflects the substantial progress Baker Hughes has made in executing our strategic transformation. Reflecting on the financial successes achieved during Horizon 1, we drove record results last year while taking key actions across the Company to significantly expand margins.&#8221;
&#8220;As part of his previous roles in Baker Hughes, and as well as currently leading free cash flow efforts across the Company, Moghal has developed unique insights into our business and broad portfolio that will ensure we efficiently allocate capital to drive profitable growth while remaining focused on continuous margin improvement.&#8221;
Read: <a target="_blank" href="https://www.benzinga.com/25/02/43433329/baker-hughes-lands-exxonmobil-guyana-deal-partners-with-hanwha-on-ammonia-turbines" rel="noreferrer noopener">Baker Hughes Lands ExxonMobil Guyana Deal, Partners With Hanwha On Ammonia Turbines</a>
Outlook: The company reiterated its first-quarter and full-year 2025 guidance of another strong year of EBITDA growth, targeting a 20% EBITDA margin for its OFSE segment in 2025 and <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">for the IET segment in 2026</a>.
Additionally, the company is committed to returning 60% to 80% of<a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener"> free cash flow to shareholders</a>.
Last month, Baker Hughes reported fourth-quarter adjusted EPS of $0.70, surpassing the $0.63 estimate, and sales of $7.36 billion, <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/g43356061/baker-hughes-announces-fourth-quarter-and-full-year-2024-results" rel="noreferrer noopener">beating the $7.08 billion estimate</a>.
Investors can gain exposure to the stock via iShares U.S. Oil Equipment &amp; Services ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IEZ#NYSE">IEZ</a>) and&nbsp;VanEck Oil Services ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OIH#NYSE">OIH</a>).
Price Action: BKR shares are down 1.67% at $44.86 at the last check Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/02/43540757/oil-prices-trim-losses-as-department-of-treasury-issues-sanctions-on-irans-crude-shipments-to-china" target="_blank" rel="noreferrer noopener">Oil Prices Trim Losses As Department Of Treasury Issues Sanctions On Iran&#8217;s Crude Shipments To China</a></li>
</ul>
Image via Shutterstock.

Guidance

Management

iShares Dow Jones US Oil Equipment & Services Index Fund

Baker Hughes Appoints Ahmed Moghal As CFO, Reaffirms Growth Targets

<a href="https://www.axios.com/2025/02/24/ukraine-mineral-deal-zelensky-trump" title="https://www.axios.com/2025/02/24/ukraine-mineral-deal-zelensky-trump">https://www.axios.com/2025/02/24/ukraine-mineral-deal-zelensky-trump</a>

Global

"Inside The Proposed U.S.-Ukraine Minerals Deal" - Axios

<a href="https://x.com/mingchikuo/status/1894054674384523347" title="https://x.com/mingchikuo/status/1894054674384523347">https://x.com/mingchikuo/status/1894054674384523347</a>

Analyst Ratings

Analyst Ming-Chi Kuo Post On X "The first Panther Lake engineering samples, made with Intel/IFS's 18A, are currently being tested by major PC ODM/EMS makers. My early 2025 industry survey showed 18A yields below 20-30%, so there's still a lot of room to step up—which doesn't bode well for Intel's goal of hitting mass production in 2H25. On top of the tech challenges, IFS faces a big obstacle in winning outside orders due to its org setup, supply chain mgt, and culture. That's where TSMC totally stands out"

https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-names-former-fda-director-patrizia-cavazzoni-chief-medical-officer-2025-02-24/#:~:text=Feb%2024%20(Reuters)%20%2D%20Pfizer,other%20medical%20functions%20at%20Pfizer

'Pfizer Names Former FDA Director Patrizia Cavazzoni As Chief Medical Officer' - Reuters News

<a href="https://x.com/ATT/status/1894043199322136741" title="https://x.com/ATT/status/1894043199322136741">https://x.com/ATT/status/1894043199322136741</a>

AT&T Posts On X "Good things come to those who wait... but gre[A]t things come with one phone call. Stay tuned..."

<a href="https://www.windowscentral.com/software-apps/office-365/microsoft-quietly-launches-free-ad-supported-version-of-office-apps-for-windows-with-limited-functionality" title="https://www.windowscentral.com/software-apps/office-365/microsoft-quietly-launches-free-ad-supported-version-of-office-apps-for-windows-with-limited-functionality">https://www.windowscentral.com/software-apps/office-365/microsoft-quietly-launches-free-ad-supported-version-of-office-apps-for-windows-with-limited-functionality</a>

MSFT

'Microsoft Quietly Launches Free, Ad-Supported Version Of Office Apps For Windows With Limited Functionality' - Windows Central

In the current session, the stock is trading at $77.40, after a 0.66% spike. Over the past month, Southwest Gas Hldgs Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SWX#NYSE">SWX</a>) stock increased by 4.98%, and in the past year, by 24.02%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.

<img src="https://www.benzinga.com/files/images/story/2025/1740416418_0.png" alt="Past Year Chart" />

<h3>How Does Southwest Gas Hldgs P/E Compare to Other Companies?</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Southwest Gas Hldgs has a better P/E ratio of 30.76 than the aggregate P/E ratio of 17.93 of the Gas Utilities industry. Ideally, one might believe that Southwest Gas Hldgs Inc. might perform better in the future than it's industry group, but it's probable that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1740416418_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

P/E Ratio Insights for Southwest Gas Hldgs

Wall Street took a step back from record highs last week as inflation concerns and a weaker consumer spending outlook <a href="https://www.benzinga.com/topic/inflation">weighed on markets</a>. 
Walmart's downbeat profit forecast sent its stock tumbling, while the Federal Reserve made it clear that it needs more proof of cooling inflation before considering rate cuts. 
Meanwhile, Chinese tech stocks had a strong week, led by Alibaba, as investors bet on policy easing from China's central bank.
Amid the market's mixed performance, <a href="https://www.benzinga.com/etfs">several ETFs stood out</a> with impressive gains. Here they are:
1. United States Natural Gas Fund LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNG#NYSE">UNG</a>)
<ul>
<li>Weekly Gains:&nbsp;20.33%</li>
<li>Focus:&nbsp;Aims to mirror the daily price movements of natural gas.&nbsp;</li>
<li>Expense Ratio:&nbsp;1.01%</li>
</ul>
Also Read: <a href="https://in.benzinga.com/25/02/43794096/top-wall-street-forecasters-revamp-occidental-petroleum-price-expectations-ahead-of-q4-earnings">Top Wall Street Forecasters Revamp Occidental Petroleum Price Expectations Ahead Of Q4 Earnings</a>
2. ProShares Ultra Bloomberg Natural Gas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOIL#NYSE">BOIL</a>) 
<ul>
<li>Weekly Gains:&nbsp;25.64%</li>
<li>Focus:&nbsp;Aims to achieve daily results corresponding to two times the daily performance of the Bloomberg Natural Gas Subindex.</li>
<li>Expense Ratio:&nbsp;1.61%</li>
</ul>
3. Breakwave Dry Bulk Shipping ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BDRY#NYSE">BDRY</a>) 
<ul>
<li>Weekly Gains:&nbsp;25.64%</li>
<li>Focus:&nbsp;Offers exposure to dry bulk shipping, aiming to profit from gains in freight futures beyond what is already priced in.</li>
<li>Expense Ratio:&nbsp;3.50%</li>
</ul>
4. Defiance Daily Target 2X Long SMCI ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCX#NASDAQ">SMCX</a>) 
<ul>
<li>Weekly Gains:&nbsp;120.33%</li>
<li>Focus:&nbsp;Aims leveraged results of two times the daily percentage change Super Micro Computer, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>).</li>
<li>Expense Ratio:&nbsp;1.29%</li>
</ul>
5. Direxion Daily Semiconductor Bull 3x Shares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOXL#NYSE">SOXL</a>) 
<ul>
<li>Weekly Gains:&nbsp;14.27%</li>
<li>Focus:&nbsp;Aims daily results of 300% of the performance of the NYSE Semiconductor Index.</li>
<li>Expense Ratio:&nbsp;0.92%</li>
</ul>
<h3 class="wp-block-heading">What Happened In The Market Last Week?</h3>
Natural gas prices rebounded on expectations of higher demand and supply constraints. Reuters reported that according to Energy Information Administration data, U.S. crude oil stockpiles&nbsp;rose a little more than anticipated and fuel inventories dropped last week due to seasonal maintenance at refineries.
On the stock side, Super Micro Computer jumped 16.5% after releasing <a href="https://www.benzinga.com/general/market-summary/25/02/43901002/benzinga-bulls-and-bears-smci-jet-ai-palantir-and-oxy-and-wall-street-retreats-from-record-highs">strong preliminary Q1 results</a> and reassuring investors about its delayed financial filings. 
Jet.AI Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JTAI#NASDAQ">JTAI</a>) soared 69% after announcing plans for a massive AI data center in Nevada, tapping into the growing demand for AI infrastructure.
In the U.S. and Canada, 10-year government bond yields surged in mid-January due to strong economic data, inflation uncertainty, and <a href="https://www.edwardjones.ca/ca-en/market-news-insights/stock-market-news/stock-market-weekly-update">expectations </a>that the Fed would limit rate cuts in 2025, according to Edward Jones. However, in recent weeks, yields have stabilized and started to decline.
With inflation still a big concern and earnings sending mixed signals, investors are keeping a close eye on economic data and any hints about future Fed policy moves.
Now Read:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/02/43916277/streaming-stocks-revenues-quadrupled-but-shares-dropped-35-analyst-thinks-he-knows-why">Streaming Stock&#8217;s Revenues Quadrupled, But Shares Dropped 35% &#8211; Analyst Thinks He Knows Why</a></li>
</ul>
Image: Shutterstock

Broad U.S. Equity ETFs

ETFs

ACHR

BDRY

BOIL

JTAI

PLTR

SMCI

SMCX

SOXL

Wall Street Retreats As Inflation Worries Mount, 5 ETFs That Stood Strong Last Week

WIIM

Floor & Decor shares are trading higher after Stifel upgraded the stock from Hold to Buy and raised its price target from $100 to $110.

Conglomerate Berkshire Hathaway (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>)(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) shares hit all-time highs Monday on the heels of the company's<a href="https://www.benzinga.com/25/02/43900955/berkshire-hathaways-q4-profits-soar-71-warren-buffett-says-his-firm-has-paid-more-taxes-than-tech-titans-in-trillions"> annual shareholder letter</a> from CEO Warren Buffett.
An analyst sees more upside ahead after the report.
The Berkshire Hathaway Analyst: Keefe, Bruyette &amp; Woods analyst Meyer Shields maintains a Market Perform rating and raised the price target on Class A shares (BRK-A) from $750,000 to $775,000.
You may not be a billionaire like Warren Buffett, but you can uncover hidden gems in the stock market using our proprietary data and pattern recognition — <a href="https://www.benzinga.com/trading-ideas/25/02/43900861/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet-54">check out five stocks flying under the radar that deserve your attention.</a>
The Analyst Takeaways: Berkshire beat Street estimates for operating earnings per share in the fourth quarter, helped by higher-than-expected insurance underwriting and insurance income, Shields said in a new investor note.
The analyst said <a href="https://www.benzinga.com/trading-ideas/25/02/43893285/warren-buffetts-annual-shareholder-letter-arrives-saturday-could-investors-get-updates-on-apple-succession-new-investments">the insurance segment</a>, which included strong results from the company's GEICO division, was enough to offset lower-than-expected results from segments like railroads, utilities and energy.
For the consumer products segment, Jazwares was highlighted by the analyst as having lower revenue that offset gains for the company's apparel, footwear and Duracell brands inside the segment.
Shields raises 2025 earnings per share estimates based on higher insurance income.
"We expect the EPS beat and GEICO's strong underwriting results to boost BRK's shares on Monday," Shields said.
While Shields raised the price target, the market perform rating remains with the analyst saying items like ongoing macro uncertainty and the management succession risks potential negatives for the company.
"We don't recommend Berkshire's stock over broader indices."
The analyst is cautious on Berkshire's non-insurance units, which are more likely to have growth and margin expansion in 2026.
"We think that Berkshire's size and diversification point to broadly in-line performance with the S&amp;P 500."
Shields said Buffett's annual shareholder letter "was fairly short and contained little new information."
BRK-A Price Action: Berkshire stock is up 3.93% to $747,000 on Monday, hitting a new all-time high of $749,611.40 earlier in the trading session. The company is now valued at $1.07 trillion and passed Tesla Monday as the eighth highest-valued public company in the world.
Berkshire stock is up 21% over the last year, outpacing the 18.3% gain for the SPDR S&amp;P 500 ETF Trust, which tracks the S&amp;P 500.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/education/25/01/42832123/warren-buffett-beats-sp-500-in-2024-how-oracle-of-omahas-returns-compare-over-past-20-years">Warren Buffett Beats S&amp;P 500 In 2024, How Oracle Of Omaha&#8217;s Returns Compare Over Past 20 Years</a></li>
</ul>
Photo: Shutterstock

Comments

Telix Pharmaceuticals

Telix Pharmaceuticals (TLX) オプション

No option chain data available. Please try again later

ニュース

パートナーシップ

ベンジンガ・グローバル